Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations

American Journal of Roentgenology

Volumn 190, Issue 4, 2008, Pages 966-971

  Yong, Chen ^a   Yanhao, Li ^a   Qiaohua, Zhu ^a   Qingle, Zeng ^a   Jianbo, Zhao ^a   Xiaofeng, He ^a   Quelin, Mei ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fluoroscopic injection; Orbital venous malformations; Pingyangmycin lipiodol emulsion; Sclerotherapy

Indexed keywords

ANTIINFLAMMATORY AGENT; BLEOMYCIN A5; IODINATED POPPYSEED OIL; BLEOMYCIN; DRUG DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIPLOPIA; DRUG EFFICACY; DRUG SAFETY; EMULSION; EXOPHTHALMOS; EYE MOVEMENT DISORDER; FEMALE; FLUOROSCOPY; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; ORBIT TUMOR; ORBITAL VENOUS MALFORMATION; PAIN; PHLEBOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLEROTHERAPY; TREATMENT OUTCOME; VISUAL ACUITY; CHILD; INTRALESIONAL DRUG ADMINISTRATION; METHODOLOGY; ORBIT; PATHOLOGY; VASCULARIZATION; VEIN;

ADOLESCENT; ADULT; BLEOMYCIN; CHILD; EMULSIONS; FEMALE; FLUOROSCOPY; HUMANS; INJECTIONS, INTRALESIONAL; IODIZED OIL; MALE; ORBIT; RETROSPECTIVE STUDIES; SCLEROTHERAPY; TREATMENT OUTCOME; VEINS;

EID: 42449095815     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2851     Document Type: Article

References (17)

1. Harris GJ. Orbital vascular malformation: a consensus statement on terminology and its clinical implication - Orbital Society. Am J Ophthalmol 1999; 127:453-455
2. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104:1-11; discussion 12-15
3. Choi YH, Han MH, O-Ki K, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 2002; 13:475-482
4. Gelbert F, Enjolras O, Deffrenne D, Aymard A, Mounayer C, Merland JJ. Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients. Neuroradiology 2000; 42:692-696
5. Arat YO, Mawad ME, Boniuk M. Orbital venous malformations: current multidisciplinary treatment approach. Arch Ophthalmol 2004; 122: 1151-1158
6. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004; 15:431-445
7. Zhang J, Chen C, Zhang Z. Intralesional injection of pingyangmycin for hemangiomas and vascular malformations in oral and maxillofacial region: a systematic review of the Chinese literature. China J Oral Maxillofacial Surg (Chin) 2003; 1:102-105
8. Zeng Q, Li Y, Chen Y, et al. Pingyangmycin lipiodol emulsion intracavitary injection in the treatment of superficial venous malformations. J Interv Radiol (Chin) 2001; 10:274-276
9. Lacey B, Rootman J, Marotta TR. Distensible venous malformations of the orbit: clinical and hemodynamic features and a new technique of management. Ophthalmology 1999; 106:1197-1209
10. Zeng QL, Li YH, Chen Y, et al. Clinical application of pingyangmycin lipiodol emulsion embolization to treat cavernous hemangioma of liver. Chin J Radiol (Chin) 2000; 34:456-458
11. Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestram I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg 1997; 31:145-150
12. Canter HI, Vargel I, Mavlll ME, Gököz A, Erk Y. Tissue response to N-butyl-2-cyanoacrylate after percutaneous injection into cutaneous vascular lesions. Ann Plast Surg 2002; 46:520-526
13. Zeng QL, Li YH, Chen Y, et al. The experimental study of intra-arterial infusion of pingyangmycinlipiodol emulsion in rabbits. J Clin Radiol (Chin) 2000; 19:376-379
14. Kong WD, Li YH, Zeng QL, Chen Y, He XF. Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells [in Chinese]. Di Yi Jun Yi Da Xue Xue Bao 2003; 23:830-832, 836
15. Zhao QX, Chen Y, Liu HR, et al. Local injection of pingyangmycin to treat ocular hemangioma. Recent Advances in Ophthalmology (Chin) 1998; 18:151-152
16. Hongbing W, Guochun L. Complications of yingyangmycin: a review. Chin J Clin Pharm (Chin) 2001; 10:53-55
17. Blum RH, Carter SK, Agre K. A clinical review of bleomycin: a new antineoplastic agent. Cancer 1973; 31:903-914